These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12740357)

  • 21. Gene expression profile associated with superimposed non-alcoholic fatty liver disease and hepatic fibrosis in patients with chronic hepatitis C.
    Younossi ZM; Afendy A; Stepanova M; Hossain N; Younossi I; Ankrah K; Gramlich T; Baranova A
    Liver Int; 2009 Oct; 29(9):1403-12. PubMed ID: 19515216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Citrin deficiency as a cause of chronic liver disorder mimicking non-alcoholic fatty liver disease.
    Komatsu M; Yazaki M; Tanaka N; Sano K; Hashimoto E; Takei Y; Song YZ; Tanaka E; Kiyosawa K; Saheki T; Aoyama T; Kobayashi K
    J Hepatol; 2008 Nov; 49(5):810-20. PubMed ID: 18620775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical treatment for obesity and its impact on non-alcoholic steatohepatitis.
    Dixon JB
    Clin Liver Dis; 2007 Feb; 11(1):141-54, ix-x. PubMed ID: 17544976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of Kupffer cells in non-alcoholic steatohepatitis of rats chronically fed with high-fat diet.
    Fan J; Zhong L; Wang G; Wu X; Li M; Jing D; Zhang P
    Zhonghua Gan Zang Bing Za Zhi; 2001 Feb; 9(1):16-8. PubMed ID: 11242127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Obesity-related non-alcoholic steatohepatitis and TGF-beta1 serum levels in relation to morbid obesity.
    Sepúlveda-Flores RN; Vera-Cabrera L; Flores-Gutiérrez JP; Maldonado-Garza H; Salinas-Garza R; Zorrilla-Blanco P; Bosques-Padilla FJ
    Ann Hepatol; 2002; 1(1):36-9. PubMed ID: 15114294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The natural history and risk factors for progression of non-alcoholic fatty liver disease and steatohepatitis.
    Miele L; Forgione A; Hernandez AP; Gabrieli ML; Vero V; Di Rocco P; Greco AV; Gasbarrini G; Gasbarrini A; Grieco A
    Eur Rev Med Pharmacol Sci; 2005; 9(5):273-7. PubMed ID: 16231589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet.
    Koppe SW; Sahai A; Malladi P; Whitington PF; Green RM
    J Hepatol; 2004 Oct; 41(4):592-8. PubMed ID: 15464239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis.
    Tsochatzis E; Papatheodoridis GV; Manesis EK; Kafiri G; Tiniakos DG; Archimandritis AJ
    Aliment Pharmacol Ther; 2008 Jan; 27(1):80-9. PubMed ID: 17919273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Non-alcoholic steatohepatitis: natural history and diagnosis].
    Larrey D
    Gastroenterol Clin Biol; 2003; 27(8-9):793-8. PubMed ID: 14586250
    [No Abstract]   [Full Text] [Related]  

  • 30. The CYP2E1 knockout delivers another punch: first ASH, now NASH. Alcoholic steatohepatitis. Nonalcoholic steatohepatitis.
    Maher J
    Hepatology; 2001 Jan; 33(1):311-2. PubMed ID: 11124851
    [No Abstract]   [Full Text] [Related]  

  • 31. Non-alcoholic steatohepatitis: another disease of affluence.
    James O; Day C
    Lancet; 1999 May; 353(9165):1634-6. PubMed ID: 10335777
    [No Abstract]   [Full Text] [Related]  

  • 32. The prevalence of steatohepatitis in chronic hepatitis B patients and its impact on disease severity and treatment response.
    Charatcharoenwitthaya P; Pongpaibul A; Kaosombatwattana U; Bhanthumkomol P; Bandidniyamanon W; Pausawasdi N; Tanwandee T
    Liver Int; 2017 Apr; 37(4):542-551. PubMed ID: 27740738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Nonalcoholic steatohepatitis].
    Jin SY
    Korean J Hepatol; 2006 Sep; 12(3):455-9. PubMed ID: 16998299
    [No Abstract]   [Full Text] [Related]  

  • 34. [Non-alcoholic steatohepatitis].
    García Monzón C
    Gastroenterol Hepatol; 2001 Oct; 24(8):395-402. PubMed ID: 11674960
    [No Abstract]   [Full Text] [Related]  

  • 35. Non-alcoholic steatohepatitis: an overview.
    Shifflet A; Wu GY
    J Formos Med Assoc; 2009 Jan; 108(1):4-12. PubMed ID: 19181602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy.
    Javor ED; Ghany MG; Cochran EK; Oral EA; DePaoli AM; Premkumar A; Kleiner DE; Gorden P
    Hepatology; 2005 Apr; 41(4):753-60. PubMed ID: 15791619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonalcoholic fatty liver disease and hepatic cirrhosis: Comparison with viral hepatitis-associated steatosis.
    Haga Y; Kanda T; Sasaki R; Nakamura M; Nakamoto S; Yokosuka O
    World J Gastroenterol; 2015 Dec; 21(46):12989-95. PubMed ID: 26675364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice.
    Larter CZ; Yeh MM; Van Rooyen DM; Teoh NC; Brooling J; Hou JY; Williams J; Clyne M; Nolan CJ; Farrell GC
    J Gastroenterol Hepatol; 2009 Oct; 24(10):1658-68. PubMed ID: 19788606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-alcoholic steatohepatitis and metabolic syndrome.
    Machado M; Cortez-Pinto H
    Curr Opin Clin Nutr Metab Care; 2006 Sep; 9(5):637-42. PubMed ID: 16912563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Non-alcoholic steatohepatitis].
    Haukeland JW; Konopski Z; Bell H; Raknerud N
    Tidsskr Nor Laegeforen; 2001 Aug; 121(20):2377-80. PubMed ID: 11603045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.